Skip to content
Shuttingdown

Aprea Therapeutics, Inc.

Pharmaceutical Preparations · DOYLESTOWN

Distress signal

Moderate confidence (50%)

Updated Oct 17, 2026, 12:04 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: Aprea Therapeutics, Inc. received a delisting notice from its exchange (Jul 23, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. Aprea Therapeutics, Inc. received a delisting notice from its exchange

    Jul 23, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing. On July 23, 2026, Aprea Therapeutics, Inc. (the Company ) received a notification letter from The Nasdaq Stock Market LLC ( Nasdaq ) informing the Company that, while the Company has not yet regained compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price Requirement ), Nasdaq has determined that the Company is eligible for an additional 180 calendar day period, or until January…”

  2. Aprea Therapeutics, Inc. received a delisting notice from its exchange

    Jan 23, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing. On January 23, 2026, Aprea Therapeutics, Inc. (the Company ) received a deficiency letter from the Nasdaq Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price R…”

Company information

Founded
—
Employees (estimate)
—
Industry
Pharmaceutical Preparations
Subindustry
—
Listing
SEC lists the ticker APRE on Nasdaq.
SEC CIK
0001781983
Website
—
LinkedIn
—
Headquarters
DOYLESTOWN
Also known as
—
Legal entities
Aprea Therapeutics, Inc.

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    Aprea Therapeutics, Inc. — Pharmaceutical Preparations (SIC 2834) — DOYLESTOWN, PA
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing. On January 23, 2026, Aprea Therapeutics, Inc. (the Company ) received a deficiency letter from the Nasdaq Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company s common stock has been below the minimum $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price R…
    View source record

  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard Transfer of Listing. On July 23, 2026, Aprea Therapeutics, Inc. (the Company ) received a notification letter from The Nasdaq Stock Market LLC ( Nasdaq ) informing the Company that, while the Company has not yet regained compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the Minimum Bid Price Requirement ), Nasdaq has determined that the Company is eligible for an additional 180 calendar day period, or until January…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:11 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:15 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:27 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.